Invention Grant
- Patent Title: Hybrid ligand, hybrid biomimetic chromedia and preparing method and use thereof
-
Application No.: US16319317Application Date: 2018-01-16
-
Publication No.: US11034723B2Publication Date: 2021-06-15
- Inventor: Shanjing Yao , Dongqiang Lin , Qilei Zhang , Xujun Zou , Huili Lu
- Applicant: ZHEJIANG UNIVERSITY
- Applicant Address: CN Zhejiang
- Assignee: ZHEJIANG UNIVERSITY
- Current Assignee: ZHEJIANG UNIVERSITY
- Current Assignee Address: CN Zhejiang
- Agency: JCIPRNET
- Priority: CN201711419375.1 20171225
- International Application: PCT/CN2018/072780 WO 20180116
- International Announcement: WO2019/127686 WO 20190704
- Main IPC: C07K1/22
- IPC: C07K1/22 ; C07K5/087 ; C07K16/00 ; B01D15/38 ; B01J20/26 ; C07K1/107

Abstract:
This invention relates to a hybrid ligand, a hybrid biomimetic chromedia and a preparing method and a use thereof, wherein the hybrid biomimetic chromedia takes hydrophilic porous microsphere as a substrate in chromatography, activated with allyl bromide and undergoing bromo-alcoholization with N-bromosuccinimide, then coupled with the hybrid ligands. The sequence of the hybrid ligand is phenylalanine-tyrosine-glutamine-5-aminobenzimidazole. The hybrid biomimetic chromedia has both of the two functional groups of phenylalanine-tyrosine-glutamine tripeptide and aminobenzimidazole, while maintaining the high antibody selectivity of polypeptide ligand, hydrophobic electric charge inductive ligand is introduced to achieve more moderate elution requirement, realizing effective antibody separation.
Public/Granted literature
- US20210009635A1 HYBRID LIGAND, HYBRID BIOMIMETIC CHROMEDIA AND PREPARING METHOD AND USE THEREOF Public/Granted day:2021-01-14
Information query